Tolleson Wealth Management, Inc. Fibrogen Inc Transaction History

Tolleson Wealth Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $2.66 Million - $3.52 Million	-71,782 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$40.47 - $45.5 $830,120 - $933,296	-20,512 Reduced 22.22%	71,782 $2.95 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $1.69 Million - $2.34 Million	-48,762 Reduced 34.57%	92,294 $3.96 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $579,624 - $759,405	-15,674 Reduced 10.0%	141,056 $5.22 Million
Q2 2019 Aug 13, 2019	BUY	$35.13 - $55.53 $3.6 Million - $5.69 Million	102,550 Added 189.28%	156,730 $7.08 Million
Q1 2019 May 09, 2019	SELL	$42.83 - $59.91 $257,836 - $360,658	-6,020 Reduced 10.0%	54,180 $2.95 Million
Q4 2018 Apr 09, 2019	BUY	$37.97 - $60.16 $2.29 Million - $3.62 Million	60,200 New	60,200 $2.79 Million

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Tolleson Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Tolleson Wealth Management, Inc. with notifications on news.